Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma: A Phase Ib Study
Authors not listed
European Organisation for Research and Treatment of Cancer - EORTC · 2018
Abstract
This is a three parallel cohort, open-labeled, non-randomized, multicenter study. All three cohorts will enroll independently.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-04 MST
Cite this
APA
Anonymous. (2018). Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma: A Phase Ib Study. <em>European Organisation for Research and Treatment of Cancer - EORTC</em>. https://clinicaltrials.gov/study/NCT03224104
Vancouver
Anonymous. Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma: A Phase Ib Study. European Organisation for Research and Treatment of Cancer - EORTC. 2018.
BibTeX
@misc{anon2018Studyo,
title = {Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma: A Phase Ib Study},
author = {Anonymous},
journal = {European Organisation for Research and Treatment of Cancer - EORTC},
year = {2018},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging Clinical and Experimental Research 2021
Open access · CC-BY
Biological Frailty Index in centenarians
Novartis Pharmaceuticals 2015
Open access · US-GOV
A 24 Week Off Drug Extension, Parallel Group, Study Assessing Durability of Effect on Skeletal Muscle Strength and Function Following a 6-month Double-blind, Placebo Controlled Study Evaluating Bimagrumab in Older Adults With Sarcopenia (InvestiGAIT Extension)
Current Oncology Reports 2021
Open access · OA
Determination of Biological Age: Geriatric Assessment vs Biological Biomarkers
University Hospital, Lille 2023
Open access · US-GOV
A Phase 2 Study of Teclistamab in Combination With Daratumumab or Lenalidomide in Elderly Patients With Newly Diagnosed Multiple Myeloma
Elsevier eBooks 2017
Citation only
Epigenetic Biomarkers for Biological Age
medRxiv 2025
Preprint · OA